Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

ASX:6KA
ASX:6KAMetals and Mining

6K Additive (ASX:6KA) Loss Deepens, Reinforcing Bearish Cash Runway and Balance Sheet Concerns

6K Additive (ASX:6KA) has released its H1 2025 numbers, posting total revenue of about $9.7 million alongside a net loss of roughly $12.8 million. This leaves investors weighing modest top line progress against ongoing red ink. The company has seen revenue move from around $7.7 million in H1 2024 to $9.7 million in H1 2025. Meanwhile, trailing 12 month revenue sits near $20.4 million against a net loss of about $26.6 million, underscoring a business that is expanding sales but still running...
NasdaqGS:HLIT
NasdaqGS:HLITCommunications

Has the Market Mispriced Harmonic After a 26.8% Drop in 2025?

Wondering if Harmonic at around $9.58 is a bargain or a value trap? You are not alone, and this is where a closer look at valuation really starts to matter. The stock has been choppy lately, up just 0.2% over the last week but still down 8.2% over the past month and 26.8% year to date. This hints that sentiment has cooled, even as the long term 5 year return of 36.7% tells a more optimistic story. Recently, investors have been weighing shifting expectations around Harmonic's broadband and...
NasdaqGS:WMT
NasdaqGS:WMTConsumer Retailing

Walmart (WMT) Net Margin Improvement Reinforces Bullish Profitability Narratives Despite Rich Valuation

Walmart (WMT) just posted its Q3 2026 numbers, with revenue of about $179.5 billion and net income of roughly $6.1 billion translating to EPS of $0.77 as investors focus on how these figures feed into the retailer’s earnings momentum story. The company has seen revenue move from around $169.6 billion in Q3 2025 to $179.5 billion in Q3 2026, while trailing twelve month net income climbed from about $19.4 billion to $22.9 billion. This sets the stage for investors to parse how sustained...
NasdaqGS:BDTX
NasdaqGS:BDTXBiotechs

Can Black Diamond Therapeutics’ (BDTX) Silevertinib CNS Data Redefine Its Precision Oncology Strategy?

Black Diamond Therapeutics recently reported topline Phase 2 data for silevertinib in first-line non-small cell lung cancer patients with non-classical EGFR mutations, and outlined plans to start a randomized Phase 2 trial in newly diagnosed glioblastoma in 2026. The early results, including strong central nervous system response rates and a broad range of EGFR alterations targeted, underscore silevertinib’s potential as a brain-penetrant precision therapy across multiple tumor types. We’ll...
NasdaqGS:SAIC
NasdaqGS:SAICProfessional Services

SAIC (SAIC) Q3 2026: Margin Expansion Reinforces Bullish Narrative Despite Revenue Pressure

Science Applications International (SAIC) opened Q3 2026 with Q2 revenue of about $1.8 billion and basic EPS of $2.72, setting the tone for another data heavy earnings season. The company has seen quarterly revenue move from $1.82 billion in Q2 2025 to $1.77 billion in Q2 2026, while EPS over that same span ranged from $1.59 to $2.72. This frames a period of shifting top line and per share results that investors will be watching closely. With trailing net profit margins now higher than a year...
TSXV:ICM
TSXV:ICMMetals and Mining

TSX Penny Stocks To Watch In December 2025

As the Canadian market navigates through policy shifts and global uncertainties, the TSX is on track for its strongest calendar-year return since 2009, rewarding investors who stayed committed during periods of volatility. In this context, understanding what makes a good investment becomes crucial; penny stocks, while an older term, continue to offer intriguing opportunities for growth. These stocks often represent smaller or newer companies that can pair strong financial health with...
NYSE:RERE
NYSE:RERESpecialty Retail

Three Stocks Estimated To Be Trading Below Intrinsic Value In December 2025

As the U.S. stock market experiences a modest uptick following key inflation data, major indices like the Dow Jones and S&P 500 are nearing all-time highs, reflecting investor optimism despite recent economic uncertainties. In this environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervalued assets amid fluctuating market conditions.
NasdaqGS:MAPS
NasdaqGS:MAPSSoftware

Performance Shipping And 2 Other Promising Penny Stocks For Your Consideration

U.S. stock indexes have recently ticked higher following key inflation data, suggesting cautious optimism among investors as they anticipate upcoming Federal Reserve policy decisions. In the context of this market environment, penny stocks remain a notable area for investors seeking potential growth opportunities outside of traditional blue-chip companies. Though the term "penny stocks" may seem outdated, these smaller or newer companies can still offer significant value and growth potential...
NasdaqGS:CALM
NasdaqGS:CALMFood

Cal-Maine Foods And 2 Top Dividend Stocks To Enhance Your Portfolio

As U.S. stock indexes experience modest gains following key inflation data, investors are closely watching the Federal Reserve's upcoming policy decisions and major corporate moves like Netflix's acquisition of Warner Bros. Discovery. In this dynamic market environment, dividend stocks such as Cal-Maine Foods can offer a reliable income stream and potential stability, making them an attractive option for those looking to enhance their portfolios amidst economic fluctuations.
TSX:DSG
TSX:DSGSoftware

Descartes Systems (TSX:DSG) Mid‑Teens EPS Growth Supports Premium Valuation Narrative

Descartes Systems Group (TSX:DSG) has just posted another steady quarter, with Q2 2026 revenue coming in at about $179.8 million and basic EPS of $0.44, underscoring consistent profitability heading into the second half of fiscal 2026. The company has seen revenue move from roughly $163.4 million in Q2 2025 to $179.8 million in Q2 2026, while basic EPS edged from $0.41 to $0.44 over the same period. This sets the stage for investors to focus on how its solid margins underpin the latest...
NYSEAM:SEB
NYSEAM:SEBFood

Seaboard (SEB): Reviewing Valuation After a 70% One-Year Share Price Surge

Seaboard (SEB) has quietly delivered a strong year, with the stock up about 81% year to date and 70% over the past year, even as recent weekly moves have turned negative. See our latest analysis for Seaboard. That surge has come with some choppiness, as the 1 month share price return of 19.32% and 90 day share price return of 11.46% contrast with a recent 7 day share price pullback. This suggests momentum is pausing rather than breaking after a 1 year total shareholder return of 70.34%. If...
NYSE:MNTN
NYSE:MNTNMedia

Is MNTN a Bargain After a 48.8% Slide and DCF Upside in 2025?

This article explores whether MNTN is a beaten-down bargain or a value trap at current levels, and what the market might be overlooking. After sliding 48.8% year to date and another 9.2% over the last month, the stock has only managed a modest 0.7% uptick in the past week. This mix hints at both lingering caution and potential rebound interest. Recent headlines have focused on MNTN’s positioning in the evolving media and ad tech landscape, including its push to differentiate in a crowded...
NYSE:AI
NYSE:AISoftware

C3.ai (AI) Q2 2026: Deepening Net Losses Reinforce Bearish Profitability Narratives

C3.ai (AI) just posted its Q2 2026 numbers, with revenue at about $75.1 million and basic EPS at roughly -$0.75, as the company continues to run at a loss. Looking back over recent quarters, revenue has moved from about $94.3 million in Q2 2025 to $75.1 million in Q2 2026. Over the same period, basic EPS shifted from around -$0.52 to -$0.75, and trailing 12 month EPS now sits near -$2.84 alongside revenue of roughly $352.9 million. This sets the stage for a results season where investors are...